-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On August 5, Hengrui Pharmaceuticals issued an announcement stating that the company has recently received the "Notice of Drug Clinical Trial Approval" for the HR19003 patch approved by the National Medical Products Administration, agreeing to use this product for post-herpetic neuralgia.
Shingles is a cluster of herpes distributed along the nerves caused by varicella-zoster virus infection
This product can penetrate the skin around the peripheral nerves of the medication site, block the sodium ion channel on the nerve cell membrane, inhibit the flow of sodium ions into the nerve fiber cell membrane, block nerve excitement and conduction, and produce reversible local block, thereby achieving analgesia and anesthesia The effect
After inquiring the EvaluatePharma database, Lidoderm®'s global sales in 2020 are approximately US$345 million, and Ztlido®'s global sales in 2020 are approximately US$26 million.